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Abstract: The Danish Urogynaecological Database is established in order to ensure high 
quality of treatment for patients undergoing urogynecological surgery. The database contains 
details of all women in Denmark undergoing incontinence surgery or pelvic organ prolapse 
surgery amounting to ∼5,200 procedures per year. The variables are collected along the course 
of treatment of the patient from the referral to a postoperative control. Main variables are prior 
obstetrical and gynecological history, symptoms, symptom-related quality of life, objective 
urogynecological findings, type of operation, complications if relevant, implants used if relevant, 
3–6-month postoperative recording of symptoms, if any. A set of clinical quality indicators 
is being maintained by the steering committee for the database and is published in an annual 
report which also contains extensive descriptive statistics. The database has a completeness of 
over 90% of all urogynecological surgeries performed in Denmark. Some of the main variables 
have been validated using medical records as gold standard. The positive predictive value was 
above 90%. The data are used as a quality monitoring tool by the hospitals and in a number of 
scientific studies of specific urogynecological topics, broader epidemiological topics, and the 
use of patient reported outcome measures.
Keywords: urogynecology, pelvic organ prolapse surgery, incontinence surgery, surgical 
 quality monitoring
Introduction and aims of database
Urogynecology concerns pelvic floor dysfunction in women resulting in urinary 
incontinence (UI) and pelvic organ prolapse (POP). These conditions are never life 
threatening, but both can greatly impair quality of life and sexual function. The 
prevalence is high and increases with age. For UI, the prevalence is ∼10% at 20 years 
of age increasing to 40% at 90.1 For symptomatic POP, it increases from 30% among 
30–39 years of age to 41% among 70–79 years.2 First-line treatment in Denmark is 
hormone replacement, pelvic floor training, vaginal pessaries, and sometimes other 
medical therapies. More severe cases are treated with surgery and the lifetime risk of 
POP surgery has been estimated to be 6%–18% and about 5%–10% for UI surgery.2 
In order to monitor the clinical quality of urogynecological surgery in Denmark, the 
Danish Urogynaecological Database (DugaBase) was implemented.
There are several aims of DugaBase: i) to ensure a high and homogeneous quality 
of treatment throughout the nation; ii) to provide early warning if new urogynecological 
surgical procedures or devices may be associated with complications; iii) to provide 
data for research purposes and iv) to allow each gynecological department immediate 
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online access to the department’s own DugaBase data making 
it a valuable tool for monitoring the performance.
Study population
DugaBase was established in 2006 and fully implemented in 
2007. All women undergoing UI or POP surgery are eligible to 
be included in the DugaBase (according to the “Nordic Classi-
fication of Surgical Procedures” for UI: KKDG00; KKDG01; 
KKDG10; KKDG30; KKDG31; KKDG40; KKDG50; 
KKDG96; KKDG97; KKDV20; KKDV22; KLEG00; 
KLEG10; KLEG10A; KLEG20; and KLEG96; and for POP: 
KLEF00; KLEF60; KLEF63; KLEF64; KLEF23; KLEF50; 
KLEF51; KLEF53; KLEF03; KLEF40; KLEF41; KLEF43; 
or KLCD10/KLDC10 in combination with ICD10 diagnose 
DN81.x) (An exact and updated list of included surgical 
codes is found in the latest annual report).3 Data collection 
starts from referral to hospital and ends at the postoperative 
control. All information is manually and consecutively entered 
by the respective hospital departments and private hospital/
clinics into a web-based national input module designed and 
stored exclusively for DugaBase. The number of procedures 
per year is around 4,100 POP-related surgeries. The number 
of UI-related surgeries has decreased from 1,545 in 2010 
to 1,164 in 2014. By November 2015, the total number of 
procedures recorded in DugaBase was 41,000.
In Denmark (population ∼5.5 million people), all citizens 
have free access to a tax supported health care system, and its 
uniform organization allowed us to use a population-based 
study design.4 The availability of nationwide Danish registries 
makes it possible to retrieve data from The Danish National 
Patient Registry (NPR) about patients undergoing urogyne-
cological surgical procedures, defined by the relevant surgical 
code. In general, the NPR is of high quality with positive 
predictive values of 94%–100% for surgical procedures5–7 
and is therefore used as gold standard for the completeness 
of DugaBase. (Database completeness is here defined as enti-
ties that as a minimum contain a personal ID number linked 
to a surgical code and a date matching the data in the NPR). 
In 2010, the completeness for UI was 89.2% and for POP 
86.7% using the NPR as reference.8 Since 2011, DugaBase 
contains more than 90% of all UI and POP procedures using 
the NPR as gold standard.9 In order to achieve and maintain 
the high database completeness, the departments performing 
urogynecological surgery can continuously compare data on 
patient ID linked to surgical code from the NPR with the data 
entered into DugaBase. The completeness of the datasets 
(apart from the ID, surgical code, and date of surgery)  varies, 
ranging from 39% for data on alcohol intake to 99% for data 
on symptoms.9
Main variables
The DugaBase data consist of six parts: Part one contains 
basic information on referral, such as referral diagnosis, date 
of referral, and referring party. Part two contains informa-
tion from a validated patient questionnaire on symptoms and 
disease-specific quality of life10,11 and information on parity, 
mode of prior deliveries, prior urogynecological surgery, 
 current tobacco and alcohol consumption, and height and 
weight. Part three is a questionnaire which is completed by 
the gynecologist, based on a preoperative POP examina-
tion and, if relevant, urodynamic measurements as well as 
data on the patient’s preoperative status according to the 
American Society of Anesthesiologists classification. Part 
four includes information about the surgical procedures, the 
surgeons’ experience (self-reported total number of the same 
procedure), and company-specific products (mesh types/sling 
materials). The fifth and sixth parts record follow-up data 
entered respectively by the patient and the physician. The 
patient’s part includes the same validated questionnaire as 
part two to allow assessment of improvement. The physician 
records possible complications and reoperations occurring 
after discharge from hospital as well as a final status. The 
follow-up part is usually completed within 3–6 months of 
surgery.
A full list of variables (in Danish) is available at the 
database website.12
The variables form the background for a set of 16 clinical 
quality indicators (see Table 1). The clinical quality indica-
tors are defined and revised by the steering committee. The 
indicators are chosen in order to monitor key points in clini-
cal quality, such as patient satisfaction and reoperation rates, 
which by the steering committee are considered as logical 
endpoints. One of the 15 indicators represents waiting time 
from referral to first visit, as this indicator is regulated by 
law. Data on process are not being used as indicators at the 
present time, but this is under consideration.
Each department’s performance with regard to these 
 quality indicators is calculated and presented in an annual 
report with the comments and recommendations of the 
steering committee and eventual comments from the gyneco-
logical departments involved. Moreover, the annual report 
contains additional information on various aspects, such as 
database completeness, annual trends in quality indicator 
results, and descriptive statistics.
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Further follow-up
Apart from the follow-up included in each course, no other 
follow-up is planned. As the collection of data is ongoing, 
any recurrent surgery will be recorded in the database. This 
is monitored by quality indicators of recurrent surgery within 
2 and 5 years after primary surgery (see Table 1, indicators 
11–18).
Examples of research
DugaBase has provided data for several published articles 
and a PhD thesis13 and a number of publications and theses 
are in progress.
A validation study showed that the overall percent agree-
ment between DugaBase data and data compiled from the medi-
cal records was at least 90% for a number of key variables.8
The use of patient reported outcome measures has been 
found to be a valid tool for monitoring success of treatment 
for this group of patients.14 A study has shown how the use 
of anti-incontinence medicine preoperatively is a strong 
predictor for continued use of the same kind of medicine 
after incontinence surgery.15
The mentioned publications have reported both on mat-
ters of national interest (differences in registration between 
public and private hospitals within Denmark)16 and of 
international interest as the DugaBase has been part of an 
international study comparing POP and IU surgery in the 
OECD contries.17
Administrative issues and funding
DugaBase is a national clinical database approved by the 
Danish Health and Medicines Authority to monitor the 
health professional services in this disease area (record 
no. 7-201-03-11/1/KIKR). For all public and private 
 departments and clinics, it is mandatory by Danish law to 
Table 1 10.3 Clinical indicators
Indicator number and domain Indicator Type Standard (%)
1. Waiting time 30 days Time from receipt of referral at the hospital to  
the first visit to the hospital
process Minimum 90
3. UI: subjective patient assessment of  
success
Subjective patient assessment of success after  
surgery for UI
Result Minimum 70
6. pOp: objective score on pOp after  
surgerya
Objective measure of success of surgery for  
pOp, assessed by grade of prolapse. The goal is  
# stage 1
Result Minimum 90
7. pOp: subjective patient assessment  
of success
patient satisfaction after surgery for pOp Result Minimum 80
9. UI: further need for treatmentb Need of further treatment after surgery for UI Result Maximum 10
10. pOp: further need for treatmentb Need of further treatment after surgery for pOp Result Maximum 10
11. UI: reoperation 2 years after sling  
surgery
Reoperation 2 years after sling surgery following  
UI recurrence
Result Maximum 5
12. UI: reoperation 5 years after sling  
surgery
Reoperation 5 years after sling surgery following  
UI recurrence
Result Maximum 5
13. Reoperation 2 years after surgery  
for pOp in anterior compartment
Reoperation 2 years after operation for prolapse  
in the anterior compartment
Result Maximum 5
14. Reoperation 5 years after surgery  
for pOp in anterior compartment
Reoperation 5 years after operation for prolapse  
in the anterior compartment
Result Maximum 10
15. Reoperation 2 years after surgery  
for pOp in middle compartment
Reoperation 2 years after operation for prolapse  
in the middle compartment
Result Maximum 5
16. Reoperation 5 years after surgery  
for pOp in middle compartment
Reoperation 5 years after operation for prolapse  
in the middle compartment
Result Maximum 10
17. Reoperation 2 years after surgery  
for pOp in posterior compartment
Reoperation 2 years after operation for prolapse  
in the posterior compartment
Result Maximum 5
18. Reoperation 5 years after surgery  
for pOp in posterior compartment
Reoperation 5 years after operation for prolapse  
in the posterior compartment
Result Maximum 10
19.c Subjective patient assessment after  
surgery for UI using the pGI-I scale
Subjective patient assessment after surgery for  
UI using the pGI-I scale
Result Minimum 90
20.c Subjective patient assessment after  
surgery for pOp using the pGI-I scale
Subjective patient assessment after surgery for  
pOp using the pGI-I scale
Result Minimum 90
Notes: aIndicator stopped in 2013; bindicator stopped in 2015; cindicator introduced in 2013. The clinical indicators used for annually reporting from the DugaBase 
(2015).
Abbreviations: DugaBase, Danish Urogynaecological Database; UI, urinary incontinence; pOp, pelvic organ prolapse; pGI-I, patient Global Impression of Improvement.
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report data to an approved national clinical database. Further 
individual patient consent or Ethics Review Board approval 
is not required according to Danish law when the data are 
used to monitor, secure, and improve the quality of the surgi-
cal procedures.
DugaBase is funded by the Danish Regions (the Danish 
 public authority running the secondary health care). It works 
within the framework of the Danish Clinical Registries (RKKP) 
by Danish Regions. The database has a steering committee 
consisting of clinical urogynecologists from all regions and 
representatives with epidemiologic and data management 
expertise.
The institution responsible for the epidemiological and 
biostatistical support, including preparation of annual reports, 
is the Center for Clinical Epidemiology, Odense University 
Hospital. The annual reports and further information about 
the database (in Danish) can be accessed by the database 
website.12
Conclusion
DugaBase is an established well-validated database record-
ing variables from around 90% of all POP and UI surgeries 
in Denmark. The variables are recorded along the course of 
contact to the hospital from which the patient is referred to a 
3–6 month post operative control. The variables consist both 
of physician and patient reported data. An annual report is 
produced focusing on a number of clinical quality indicators 
concerning surgical complications, patient reported outcome 
measures, and recurrence of surgery.
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